首页> 外文期刊>International journal of obstetric anesthesia >Intrathecal epinephrine in combined spinal-epidural analgesia for labor: dose-response relationship for epinephrine added to a local anesthetic-opioid combination.
【24h】

Intrathecal epinephrine in combined spinal-epidural analgesia for labor: dose-response relationship for epinephrine added to a local anesthetic-opioid combination.

机译:鞘内注射肾上腺素联合进行脊柱-硬膜外分娩镇痛:将肾上腺素与局部麻醉药-阿片类药物合用时的剂量反应关系。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The purpose was to investigate the dose-response relationship for intrathecally administered epinephrine added to a local anesthetic-opioid combination in combined spinal-epidural analgesia for labor, in order to evaluate analgesia and side-effects. PATIENTS AND METHODS: The subjects were 100 consecutive ASA I or II parturients at 37 weeks' gestation, who received combined spinal-epidural analgesia during labor. Each woman was randomly assigned to one of five groups that received 2-mL volumes of different spinal solutions. The control group received an intrathecal injection of bupivacaine 2.5 mg and fentanyl 25 microg only. The others received epinephrine 12.5, 25, 50 or 100 microg added to this intrathecal regimen. Maternal arterial pressure, heart rate and pain scores were recorded before and 5, 10, 15 and 30 min after intrathecal injection. Level of sensory blockade, motor blockade score, duration of intrathecal analgesia, side effects, fetal heart rate, and 1- and 5-min Apgar scores were also assessed. RESULTS: Compared to the control group, all four epinephrine groups had significantly longer duration of intrathecal analgesia, but the durations were similar. The frequencies of side effects were similar in all five groups. CONCLUSION: The results suggest that adding epinephrine to a combination of standard intrathecal doses of bupivacaine and fentanyl in combined spinal-epidural analgesia for labor significantly prolongs spinal analgesia. Of the four epinephrine doses tested, the lowest one (12.5 microg) was optimal for this clinical setting.
机译:摘要背景:目的是研究鞘膜内联合阿片类药物联合硬膜外麻醉镇痛时鞘内注射肾上腺素的剂量-反应关系,以评估镇痛作用和副作用。患者和方法:受试者在妊娠37周时连续接受100例ASA I或II型ASA产程,在分娩过程中接受了脊柱-硬膜外联合镇痛。每个妇女被随机分配到接受2mL体积的不同脊髓溶液的五组中的一组。对照组仅鞘内注射布比卡因2.5 mg和芬太尼25 microg。其他人接受鞘内注射的肾上腺素12.5、25、50或100微克。鞘内注射之前和之后5、10、15和30分钟记录母体动脉压,心率和疼痛评分。还评估了感觉阻滞水平,运动阻滞评分,鞘内镇痛持续时间,副作用,胎儿心率以及1分钟和5分钟Apgar评分。结果:与对照组相比,所有四个肾上腺素组鞘内镇痛的持续时间均明显更长,但持续时间相似。在所有五个组中,副作用的发生频率相似。结论:结果表明,在鞘内注射标准剂量的布比卡因和芬太尼的联合鞘内联合硬膜外分娩镇痛药中加入肾上腺素可显着延长脊髓镇痛作用。在所测试的四次肾上腺素剂量中,最低剂量(12.5微克)对于该临床环境是最佳的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号